Manolis Antonis S, Melita Helen
Third Department of Cardiology, Athens University School of Medicine, Athens, Greece.
Central Laboratories, Onassis Cardiac Surgery Center, Athens, Greece.
Pacing Clin Electrophysiol. 2017 Jan;40(1):26-34. doi: 10.1111/pace.12996. Epub 2017 Jan 17.
Cardiac implantable electronic device (CIED) implantation is complicated by infection still at a worrisome rate of 2-5%. Since early on during device implantation procedures, we have adopted an infection-preventive technique which has hitherto resulted in effective prevention of infections. Herein we present our results of applying this technique by a single operator in a prospective series of 762 consecutive patients undergoing device implantation.
A meticulous search for and treatment of active, occult, or smoldering infection was undertaken preoperatively. An aseptic/antiseptic technique was used for implantation of each device. Skin preparation is thorough with initial cleansing performed with alcohol followed by povidone-iodine 10% solution, which is also used in the wound and inside the pocket. In addition, we routinely use double gloving, and IV antibiotic prophylaxis 1 hour before and for 48 hours afterwards followed by oral antibiotic for 2-3 days after discharge. The skin is closed with absorbable sutures. The study includes 382 patients having a new pacemaker (n = 333) or battery change, system upgrade or lead revision (n = 49), and 380 patients having a new implantable cardioverter-defibrillator (ICD) (n = 296) or device replacement/upgrade/lead revision (n = 84).
The pacemaker group, aged 70.2 ± 16.5 years, includes 18% VVI, 49% DDD, 29% VDD, and 4% cardiac resynchronization therapy (CRT) devices. The ICD group, aged 61.3 ± 13.0 years, with a mean ejection fraction of 36 ± 13%, includes 325 ICD and 55 CRT implants. Over 26.6 ± 33.4 months for the pacemaker group and 36.6 ± 38.3 months for the ICD group, infection occurred in one patient in each group (0.26%) having a device replacement.
A consistent and strict approach of aseptic/antiseptic technique with the use of double gloving and povidone-iodine solution within the pocket plus a 4-day regimen of antibiotic prophylaxis minimizes infections in CIED implants.
心脏植入式电子设备(CIED)植入术后感染并发症发生率仍高达2%-5%,令人担忧。自设备植入手术早期起,我们就采用了一种感染预防技术,迄今为止已有效预防了感染。在此,我们展示了由一名操作者在762例连续接受设备植入的前瞻性系列患者中应用该技术的结果。
术前对活动性、隐匿性或潜在感染进行细致排查和治疗。每台设备植入均采用无菌/抗菌技术。皮肤准备充分,先用酒精进行初步清洁,再用10%聚维酮碘溶液,伤口及囊袋内部也使用该溶液。此外,我们常规使用双层手套,并在术前1小时及术后48小时静脉给予抗生素预防,出院后口服抗生素2-3天。皮肤用可吸收缝线缝合。该研究包括382例植入新起搏器(n = 333)或更换电池、系统升级或导线修复(n = 49)的患者,以及380例植入新植入式心律转复除颤器(ICD)(n = 296)或设备更换/升级/导线修复(n = 84)的患者。
起搏器组患者年龄为70.2±16.5岁,其中VVI起搏器占18%,DDD起搏器占49%,VDD起搏器占29%,心脏再同步治疗(CRT)设备占4%。ICD组患者年龄为61.3±13.0岁,平均射血分数为36±13%,包括325例ICD植入和55例CRT植入。在起搏器组随访26.6±33.4个月、ICD组随访36.6±38.3个月期间,每组各有1例进行设备更换的患者发生感染(0.26%)。
采用一致且严格的无菌/抗菌技术,使用双层手套及囊袋内注入聚维酮碘溶液,并进行为期4天的抗生素预防方案,可将CIED植入术后感染降至最低。